Clinical Trial Update: Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China [Phase 4]

View source ↗

Summary

This is an update on a Phase 4 clinical trial in China evaluating primary and secondary prevention of human papillomavirus (HPV)–related disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia
• Human Papillomavirus Infection

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: HPV Infections, Precancerous Disease of the Cervix | Phase 4 | Status: UNKNOWN